Imprivata is celebrating the completion of a strong 2021 campaign. The company’s total number of bookings was up 13 percent year-over-year, and those new clients were added to a roster with minimal turnover. In that regard, Imprivata achieved a stellar 98 percent customer retention rate with its existing clients.
Those two figures translated to positive growth for the company as a whole. Imprivata credited its success to a few major business developments. Most notably, the company teamed up with VMware to expand its password autofill solution to cover both Android and iOS devices instead of iOS alone. The autofill solution allows medical professionals to log into shared devices and workstations more quickly while on the job.
Imprivata also partnered with IDEMIA and Aware to bring face-based identity verification to its Electronic Prescriptions for Controlled Substances program. The joint solution pairs facial recognition tech from IDEMIA with Aware’s Knomi liveness detection technology to mitigate the threat of spoofing.
Finally, Imprivata released a new risk assessment tool to help healthcare organizations evaluate their level of exposure. The tool is based on the company’s Digital Identity Framework for protecting complex environments, which covers everything from access management and backend administration to risk analysis and patient privacy controls. The company noted that the recent rise in cybercrime has increased the demand for secure authentication options.
“The last two years have brought unprecedented challenges and complexity, particularly for healthcare organizations reeling from the effects of COVID-19,” said Imprivata CEO Gus Malezis. “We’ve spent considerable time reflecting on what we, as an organization, can do to make our customer’s lives easier while ensuring their systems and data stay secure amid a wider attack surface and targeted cyberattacks that threaten not only infrastructures, but patient safety.”
In other news, Imprivata migrated to a new headquarters in Waltham, Massachusetts, and made several changes at the executive level. Mark McArdle has signed on as the new Chief Products and Design Officer, while Tom Timperio took over as the SVP of Worldwide Engineering and Rachel McClary assumed the role of Chief Marketing Officer. Imprivata itself made it to the top of KLAS Research’s latest Best in KLAS report in February.
April 8, 2022 – by Eric Weiss